Bailey Jeffrey Allen
- SEC CIK
- 0001500210
No open-market purchases or sales filed in the past year.
Current role at each company
- AUPH Aurinia Pharmaceuticals Inc.Directoras of Jun 8, 2026
- RNTX Rein Therapeutics, Inc.Directoras of Jun 17, 2022
- BDSI Biodelivery Sciences International IncChief Executive Officeras of Mar 22, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bailey Jeffrey Allen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AUPH Aurinia Pharmaceuticals Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2024 (view filing) | Nov 11 | 1 day | Bailey Jeffrey AllenDirector | SSale | −4.56K | $8.43 | −$38.4K | −25.4%13.4K after |